Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Multiple Endocrine Neoplasia Type 1
- Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
- FOsfomycin for Male Urinary Tract Infection
- Open Label, Repeat Dose Study Evaluating YCT-529 in Healthy Males
- A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women
- Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
- Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
- 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
- Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
- Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer